-
Lilly to present data for galcanezumab for the prevention of migraine at the AAN annual meeting
cphi-online
April 24, 2017
Treatment could help to reduce the number of days lost to migraine.
-
Lilly to Present Data for Galcanezumab for the Prevention of Migraine at the American Academy of Neu
lilly
April 21, 2017
Eli Lilly and Company (NYSE: LLY) will highlight Phase 2 data evaluating galcanezumab for the prevention of migraine at the American Academy of Neurology (AAN) annual meeting, which will take place April 22-28, 2017, in Boston.
-
From bench to bedside – and back
lilly
April 14, 2017
This article is from Susan Forda, Vice-President of Global Regulatory Affairs International at Lilly.
-
Lilly Confirms Date and Conference Call for First-Quarter 2017 Financial Results Announcement
lilly
April 12, 2017
Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2017 on Tuesday, April 25, 2017.
-
Improving and extending the lives of patients with advanced breast cancer
lilly
April 11, 2017
This article comes from Fatima Cardoso, Chair ABC Global Alliance, on behalf of all members
-
Life with Type 1 Diabetes Made a Little Easier through Lilly Diabetes Scholarship Donations for Camp
lilly
April 10, 2017
Living with type 1 diabetes comes with many unique challenges in all stages of life. For parents of children with the condition, financial, medical and emotional worries can be overwhelming.
-
Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for M
lilly
April 05, 2017
Students from Ohio University's Heritage College of Osteopathic Medicine will soon join Eli Lilly and Company's (NYSE: LLY) innovative rotation program for aspiring physicians.
-
Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017
lilly
March 27, 2017
Significant investment in manufacturing diabetes medicines continues with new $85 million commitment in Indianapolis $5 billion invested in its U.S. operations over the last decade; more favorable tax climate could lead to additional U.S. investments
-
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration
lilly
March 27, 2017
Jointly developed research projects will study diabetes healthcare outcomes for the Latino population
-
WNIF: Combating Alzheimer’s Together
lilly
March 23, 2017
This article comes from Phyllis Ferrell, Lilly’s vice president and platform development leader for the global Alzheimer’s disease team.